Brandywine Global Investment Management 13F: Adds $1.3M to DOC Stake
Brandywine Global added 62,006 shares of Healthpeak, raising its stake by 1.8% to 3.45 million shares.
Reviewed by automated data checks against the source filing. How we make and check alerts
Brandywine Global Investment Management added 62,006 shares to its stake in Healthpeak Properties, Inc. ($DOC), a 1.83% increase, according to a 13F filing with the SEC dated February 11, 2026. It reported 3,446,910 shares worth $73.76 million at the end of the quarter.
Since the filing, $DOC is up 1.6% after 1 week, up 0.7% after 1 month and up 16.8% to date (from the $16.25 close on Feb 11, 2026).
Find the original: Brandywine Global Investment Management 13F filings on SEC EDGAR
Key Points
- Brandywine Global Investment Management boosted its stake in Healthpeak Properties by 1.8%, adding 62,006 shares for a total of 3,446,910 shares valued at $70.9 million as of the latest SEC filing.
- Shares of Healthpeak Properties traded near $20.56 on Wednesday with a market cap of $13.77 billion and a P/E ratio of 62.44.
- BMO Capital maintained a buy rating with a $24 target, while Morgan Stanley downgraded to hold with a $22 target.
Get $DOC trade alerts by text
We text you when insiders, Congress or big funds trade $DOC. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Healthpeak Properties, Inc. alert may contain errors. Disclosures
Brandywine Global Investment Management has increased its holdings in Healthpeak Properties, Inc. (NYSE: DOC) by 1.8%. The firm added 62,006 shares, bringing its total to 3,446,910 shares, valued at approximately $70.9 million. This information comes from the latest Form 13F filing with the SEC, reflecting positions as of the reporting period.
Brandywine Global Investment Management vs. the S&P 500
Hypothetical returns from Brandywine Global Investment Management's disclosed trades, not real profit or advice. How we model this.
What Changed in Brandywine Global's Healthpeak Properties Position
Brandywine Global's move to add 62,006 shares represents a 1.8% increase in its stake in Healthpeak Properties. The total number of shares now stands at 3,446,910, with a reported value of about $70.9 million.
Other Institutional Activity in Healthpeak Properties
Other institutional investors also made adjustments to their Healthpeak holdings. BlackRock, Inc. trimmed its holdings by 182,068 shares, resulting in a total of 73,360,519 shares worth approximately $1.2 billion. Vanguard Portfolio Management LLC opened a new position with 58,125,899 shares valued at $955 million. State Street Corp reduced its stake by 872,866 shares, ending with 48,500,600 shares worth $796.9 million. JPMorgan Chase & Co significantly increased its holdings by 14,056,729 shares, bringing its total to 44,731,541 shares valued at $740.3 million.
Healthpeak Properties, Inc. Stock Up 5.3%
On Wednesday, shares of Healthpeak Properties traded near $20.56. The company has a market capitalization of $13.77 billion and a P/E ratio of 62.44. Its forward P/E is 133.2, and the stock's beta is 1.029. Over the past 52 weeks, the stock has traded between $15.70 and $20.82. The 50-day moving average is $18.53, and the 200-day moving average is $17.76. Healthpeak Properties has a current ratio of 2.039 and a quick ratio of 1.407, with a debt-to-equity ratio of 118.243.
Recent Earnings
Healthpeak Properties reported revenue of $2.87 billion with a growth rate of 7.1%. The company's earnings per share (EPS) is $0.32, with a net margin of 7.73% and a return on equity (ROE) of 2.8%. The next earnings report is expected on August 4, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
6 target raises vs 1 cuts.
-
EPS & revenue
EPS beat estimates by 515.4%. Revenue beat estimates by 7.3%.
-
Profit surprise
EBITDA beat by 47 percent. Operating income beat sharply.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
6 target raises, 1 target cut.
-
Earnings quality
Gross margin down 81.1 points. Operating margin down 3.7 points. Positive free cash flow.
Earnings Call Summary
Healthpeak had a solid first quarter with outpatient medical leasing spreads of 5.4 percent and occupancy at 91 percent, while life science occupancy reached 77.7 percent with strong leasing momentum. The company completed the Janus Living IPO generating value and deployed $714 million into senior housing acquisitions, plus bought back $100 million of stock in April to improve future earnings. Management noted that life science market conditions are improving with strong M&A activity and capital raising, and they expect occupancy to grow at least 100 basis points by year-end.
Guidance Management expects full-year FFO between $1.71 and $1.75 per share, up from previous guidance, reflecting the successful Janus Living spin and senior housing outperformance. They plan to deploy about $750 million into acquisitions by year-end to offset IPO dilution and drive growth in 2027.
Good report. The company beat and showed some forward improvement, with a few meaningful caveats.
Dividend
Healthpeak Properties offers an annual dividend rate of $1.22, yielding 6.24%. The dividend payout ratio stands at 381.26%.
Insider Buying and Selling at Healthpeak Properties, Inc.
Recent insider activity at Healthpeak Properties includes several transactions on May 29, 2026. EVP and Treasurer Ankit Patadia bought 1,358 shares at $15.46 each and sold 94 shares at $19.15. Chief Financial Officer Kelvin Moses purchased 937 shares at $15.46. President and CEO Scott Brinker sold 114 shares at $19.15.
Analysts Set New Price Targets
On June 15, 2026, BMO Capital maintained its buy rating on Healthpeak Properties with a price target of $24. On June 11, Morgan Stanley downgraded the stock to hold, setting a target of $22. Wells Fargo, Scotiabank, and RBC Capital also maintained their ratings with varying price targets. The consensus among 18 analysts is a buy, with an average target price of $21.28.
About Healthpeak Properties
Healthpeak Properties, Inc. is a real estate investment trust (REIT) based in Denver, Colorado. The company focuses on owning and developing healthcare-related real estate across the United States. Healthpeak's portfolio includes outpatient medical buildings, labs, and continuing care retirement communities. Led by CEO Scott M. Brinker, the company employs around 411 people and is part of the S&P 500.
Bottom Line
Investors watch Healthpeak Properties for its strong position in healthcare real estate. The recent 13F filing from Brandywine Global shows an increased commitment to the stock. While institutional activity provides insights, remember that these filings reflect past positions and may not indicate current strategies.
Source: Brandywine Global Investment Management's 13F filing on $DOC (Feb 11, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Brandywine Global Investment Management 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts